<SEC-DOCUMENT>0001628280-17-000870.txt : 20170203
<SEC-HEADER>0001628280-17-000870.hdr.sgml : 20170203
<ACCEPTANCE-DATETIME>20170203170053
ACCESSION NUMBER:		0001628280-17-000870
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20170203
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20170203
DATE AS OF CHANGE:		20170203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		17572860

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k-acetadoteipupdate.htm
<DESCRIPTION>8-K - ACETADOTE IP UPDATE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s9854e337de60466b8d08491c2f07e818"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:inherit;font-size:13pt;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:inherit;font-size:13pt;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;">FORM 8-K</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CURRENT REPORT</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.671875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:51%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of Earliest Event Reported):           </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 3, 2017 (January 30, 2017)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;">Cumberland Pharmaceuticals Inc.</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">__________________________________________</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:0%;"></td><td style="width:33%;"></td><td style="width:18%;"></td><td style="width:5%;"></td><td style="width:11%;"></td><td style="width:33%;"></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Tennessee</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">001-33637</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">62-1765329</font></div></td></tr><tr><td><font>&#160;</font></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation)</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer Identification No.)</font></div></td></tr><tr><td><font>&#160;</font></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2525 West End Avenue, Suite 950, Nashville, Tennessee</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37203</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant's telephone number, including area code:     (615) 255-0068</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not Applicable</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">____________________________________________</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Former name or former address, if changed since last report</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[&#160;&#160;]&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[&#160;&#160;]&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[&#160;&#160;]&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[&#160;&#160;]&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 30, 2017, the Company issued a press release announcing the Appeals Court ruling in favor of Cumberland in a patent case associated with its Acetadote product. A copy of the press release is furnished as Exhibit 99.1 as well as the Company's updated risk disclosure related to Acetadote at Exhibit 99.2.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:68%;"></td><td style="width:32%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumberland Pharmaceuticals Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">February 3, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">By: Michael Bonner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Name: Michael Bonner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Title: Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-acetadoteupda.htm
<DESCRIPTION>EXHIBIT 99.1 - PRESS RELEASE - ACETADOTE UPDATE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sb23fcf064c44472183884df2315a22f9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;"><img src="cumberlanda02.gif" alt="cumberlanda02.gif" style="height:97px;width:428px;"></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">U.S. COURT OF APPEALS AFFIRMS CUMBERLAND PHARMACEUTICALS&#8217;</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">VICTORY IN PATENT LITIGATION CASE</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">NASHVILLE, Tenn</font><font style="font-family:inherit;font-size:12pt;">. </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(Monday, January 30, 2017) - </font><font style="font-family:inherit;font-size:12pt;">Cumberland Pharmaceuticals Inc. </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(NASDAQ:CPIX)</font><font style="font-family:inherit;font-size:12pt;">, a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced that on January 26, 2017, the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;product. </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Appeals Court ruling affirmed the September 30, 2015 decision reached by the United States District Court for the Northern District of Illinois upholding Cumberland&#8217;s patent and expressly rejecting Mylan Inc. and Mylan Institutional LLC&#8217;s challenge of patent validity.  </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cumberland developed, registered, and launched Acetadote, which is now a standard of care for the leading cause of poisoning in the U.S.  The patent that was challenged has claims associated with Cumberland&#8217;s next-generation formulation of Acetadote that is free of EDTA or any other preservative, chelating, or stabilizing agent. Through this new formulation of Acetadote, Cumberland has been able to retain a significant market share in spite of generic competition that utilizes the old formulation of the product. By ruling in Cumberland&#8217;s favor, the Appeals Court upheld the validity of the patent which encompasses Cumberland&#8217;s EDTA-Free formulation and has a term until August 2025.</font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;We are very pleased with this outcome,&#8221; said A.J. Kazimi, Cumberland CEO. &#8220;We look forward to continuing the supply of this potentially life-saving product in support of the healthcare professionals who administer it, and especially the patients who need it. Meanwhile, we will also continue to protect and defend Cumberland&#8217;s intellectual property.&#8221;</font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company continues to seek additional patent claims to protect its intellectual property associated with Acetadote and has additional patent applications related to Acetadote&#174; pending with the US Patent Trademark Office (USPTO).</font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About Cumberland Pharmaceuticals </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquisition, development, and commercialization of high-quality products that improve the quality of care for patients. The Company has a diverse product portfolio with a focus in the areas of hospital acute care and gastroenterology. </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cumberland's marketed products include Acetadote</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">acetylcysteine</font><font style="font-family:inherit;font-size:12pt;">) Injection for the treatment of acetaminophen poisoning, Caldolor</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ibuprofen</font><font style="font-family:inherit;font-size:12pt;">) Injection, the first injectable treatment for pain and fever approved in the United States, Kristalose</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">lactulose</font><font style="font-family:inherit;font-size:12pt;">) for Oral Solution, a prescription laxative, Vaprisol</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">conivaptan</font><font style="font-family:inherit;font-size:12pt;">) Injection, for the treatment of hyponatremia, Omeclamox-Pak</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;for the treatment of </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">H. pylori</font><font style="font-family:inherit;font-size:12pt;">&#32;and duodenal ulcer disease, and Ethyol</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">amifostine</font><font style="font-family:inherit;font-size:12pt;">) for Injection, for the prevention of treatment-related adverse reactions in oncology patients.  Cumberland is also dedicated to developing innovative products that address unmet medical needs. </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company&#8217;s product candidates in clinical development include: Hepatoren</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ifetroban</font><font style="font-family:inherit;font-size:12pt;">) Injection for the treatment of hepatorenal syndrome, Boxaban</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ifetroban</font><font style="font-family:inherit;font-size:12pt;">) Oral Capsule for patients suffering from aspirin exacerbated respiratory disease, Vasculan</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">TM</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">(ifetroban</font><font style="font-family:inherit;font-size:12pt;">) Oral Capsule for the treatment of systemic sclerosis and Portaban&#8482; </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">(ifetroban</font><font style="font-family:inherit;font-size:12pt;">) Oral Capsule for the treatment of portal hypertension. </font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For more information on Cumberland Pharmaceuticals Inc., please visit </font><font style="font-family:inherit;font-size:12pt;color:#0000ff;text-decoration:underline;">www.cumberlandpharma.com</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About Acetadote</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;(acetylcysteine) Injection</font></div><div style="line-height:174%;padding-bottom:13px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Used in the emergency department, Acetadote is approved in the United States to treat overdose of acetaminophen, a common ingredient in many over-the-counter medications. Acetadote is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. Serious anaphylactoid reactions, including death in a patient with asthma, have been reported in patients administered acetylcysteine intravenously. Acetadote should be used with caution in patients with asthma or where there is a history of bronchospasm. The total volume administered should be adjusted for patients weighing less than 40 kg and for those requiring fluid restriction. To avoid fluid overload, the volume of diluent should be reduced as needed. If volume is not adjusted, fluid overload can occur, potentially resulting in hyponatremia, seizure, and death. For full prescribing information, visit </font><font style="font-family:inherit;font-size:12pt;color:#0563c1;text-decoration:underline;">www.acetadote.com</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:13px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Investor Contact:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Media Contact:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:13px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Erin Smith</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Rebecca Kirkham</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:13px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Corporate Relations</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Lovell Communications</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:13px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(615) 255-0068</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">(615) 297-7766</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>updatedriskfactors.htm
<DESCRIPTION>EXHIBIT 99.2 UPDATED RISK DISCLOSURE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5efc399f08164433a9a7ab3c727f2927"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:6px;text-align:center;"><img src="cumberlanda08.jpg" alt="cumberlanda08.jpg" style="height:58px;width:264px;"></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A new formulation of Acetadote</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> &#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;( </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">acetylcysteine</font><font style="font-family:inherit;font-size:10pt;">&#32;) Injection was developed by Cumberland Pharmaceuticals Inc. (the &#8220;Company&#8221; or "Cumberland") as part of a Phase IV commitment by the Company in response to a request by the Food and Drug Administration (&#8220;FDA&#8221;) to evaluate the reduction of ethylene diamine tetraacetic acid (&#8220;EDTA&#8221;) from the product's formulation. Acetadote is indicated to prevent or lessen hepatic (liver) injury when administered intravenously within eight to ten hours after ingesting quantities of acetaminophen that are potentially toxic to the liver. The new Acetadote formulation does not contain EDTA or any other chelating or stabilization agent and is free of preservatives. The new formulation was listed in the FDA Orange Book following its FDA approval in January 2011. In April 2012, the United States Patent and Trademark Office (the &#8220;USPTO&#8221;) issued U.S. Patent number 8,148,356 (the &#8220;356 Acetadote Patent&#8221;) which is assigned to Cumberland. The claims of the 356 Acetadote Patent encompass the new Acetadote formulation and include composition of matter claims. Following its issuance, the 356 Acetadote Patent was listed in the FDA Orange Book. The 356 Acetadote Patent is scheduled to expire in May 2026, which time period includes a 270-day patent term adjustment granted by the USPTO. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following the issuance of the 356 Acetadote Patent, the Company received separate Paragraph IV certification notices from InnoPharma, Inc., Paddock Laboratories, LLC ("Paddock") and Mylan Institutional LLC challenging the 356 Acetadote Patent on the basis of non-infringement and/or invalidity. On May&#160;17, 2012, Cumberland responded to the Paragraph IV certification notices by filing three separate lawsuits for infringement of the 356 Acetadote Patent. The first lawsuit was filed against Mylan Institutional LLC and Mylan Inc. ("Mylan") in the United States District Court for the Northern District of Illinois, Eastern Division.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">The second lawsuit was filed against InnoPharma, Inc. in the United States District Court for the District of Delaware. The third lawsuit was also filed in the United States District Court for the District of Delaware against Paddock and Perrigo Company ("Perrigo").  On May&#160;20, 2012, the Company received a Paragraph IV certification notice from Sagent Agila LLC challenging the 356 Acetadote Patent.  On June 26, 2012, the Company filed a lawsuit for infringement of the 356 Acetadote Patent against Sagent Agila LLC and Sagent Pharmaceuticals, Inc. ("Sagent") in the United States District Court for the District of Delaware.  On July 9, 2012, Cumberland received a Paragraph IV certification notice from Perrigo.  On August 9, 2012, the Company filed a lawsuit for infringement of the 356 Acetadote Patent against Perrigo in the United States District Court for the Northern District of Illinois, Eastern Division.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 12, 2012, Cumberland entered into a Settlement Agreement (the &#8220;Settlement Agreement&#8221;) with Paddock and Perrigo to resolve the challenges and the pending litigation with each of Paddock and Perrigo involving the 356 Acetadote Patent.  Under the Settlement Agreement, Paddock and Perrigo admit that the 356 Acetadote Patent is valid and enforceable and that any Paddock or Perrigo generic Acetadote product (with or without EDTA) would infringe upon the 356 Acetadote Patent. In addition, Paddock and Perrigo will not challenge the validity, enforceability, ownership or patentability of the 356 Acetadote Patent through its expiration currently scheduled for May 2026. On November 12, 2012, in connection with the execution of the Settlement Agreement, the Company entered into a License and Supply Agreement with Paddock and Perrigo (the &#8220;License and Supply Agreement&#8221;).  Under the terms of the License and Supply Agreement, if a third party receives final approval from the FDA for an ANDA to sell a generic Acetadote product and such third party has made such generic version available for purchase in commercial quantities in the United States, Cumberland will supply Perrigo with an Authorized Generic version of the Company&#8217;s Acetadote product (the &#8220;Authorized Generic&#8221;).</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May&#160;18, 2012, the Company also submitted a Citizen Petition to the FDA requesting that the FDA refrain from approving any applications for acetylcysteine injection that contain EDTA, based in part on the FDA's request that Cumberland evaluate the reduction or removal of EDTA from its original Acetadote formulation. On November 7, 2012, the FDA responded to the Citizen Petition denying the Company&#8217;s request and stating that ANDAs referencing Acetadote that contain EDTA may be accepted and approved  provided they meet all applicable requirements. Cumberland believes this response contradicts the FDA's request to evaluate the reduction or removal of EDTA. On November 8, 2012, the Company learned that the FDA approved the ANDA referencing Acetadote filed by InnoPharma, Inc.  On November 13, 2012, Cumberland brought suit against the FDA in the United States District Court for the District of Columbia alleging that the FDA's denial of the Company&#8217;s Citizen Petition and acceptance for review and approval of any InnoPharma, Inc. product containing EDTA was arbitrary and in violation of law.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company found during the resulting legal proceedings that the FDA initially concluded that the original Acetadote formulation was withdrawn for safety reasons and no generic versions should be approved. The FDA later reversed its position based on the possibility of drug shortages and the presence of EDTA in other formulations. At the same time, the FDA noted that exclusively marketing a non-EDTA containing product would be preferable because it would eliminate the potential risk of EDTA.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 7, 2013, Perrigo announced initial distribution of the Company&#8217;s Authorized Generic acetylcysteine injection product.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 19, 2013, the USPTO issued U.S. Patent number 8,399,445 (the &#8220;445 Acetadote Patent&#8221;) which is also assigned to the Company. The claims of the 445 Acetadote Patent encompass the use of the 200 mg/ml Acetadote formulation to treat patients with acetaminophen overdose.   On April 8, 2013, the 445 Acetadote Patent was listed in the FDA Orange Book. The 445 Acetadote Patent is scheduled to expire in August 2025. Following the issuance of the 445 Acetadote Patent, the Company has received separate Paragraph IV certification notices from Perrigo, Sagent, and Mylan challenging the 445 Acetadote Patent on the basis of non-infringement, unenforceability and/or invalidity. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 10, 2013, the Company became aware of a Paragraph IV certification notice from Akorn, Inc. challenging the 445 Acetadote Patent and the 356 Acetadote Patent on the basis of non-infringement. On July 12, 2013, the Company filed a lawsuit for infringement of the 356 Acetadote Patent against Akorn, Inc. in the United States District Court for the District of Delaware.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 10, 2013, Cumberland announced that the FDA approved updated labeling for Acetadote.  The new labeling revises the product's indication and offers new dosing guidance for specific patient populations.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 30, 2013, the United States District Court for the District of Columbia filed an opinion granting a Summary Judgment&#160;in favor of the FDA regarding Cumberland&#8217;s November 13, 2012 suit. &#160;On November 1, 2013, the United States District Court for the District of Delaware filed opinions granting Sagent&#8217;s and InnoPharma&#8217;s motions to dismiss the Company&#8217;s May 2012 and June 2012 suits.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February18, 2014, the USPTO issued U.S. Patent number 8,653,061 (the &#8220;061 Acetadote Patent&#8221;) which is assigned to the Company. The claims of the 061 Acetadote Patent encompass the use of the 200 mg/ml Acetadote formulation to treat patients with acetaminophen overdose.  Following its issuance, the 061 Acetadote Patent was listed in the FDA Orange Book. The 061 Acetadote Patent is scheduled to expire in August 2025.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 13, 2014, the USPTO issued U.S. Patent number 8,722,738 (the &#8220;738 Acetadote Patent&#8221;) which is assigned to Cumberland.  The claims of the 738 Acetadote Patent encompass administration methods of acetylcysteine injection, without specification of the presence or lack of EDTA in the injection. Following its issuance, the 738 Acetadote Patent was listed in the FDA Orange Book and it is scheduled to expire in April 2032.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 11, 2014 and March 3, 2015, the Company became aware of Paragraph IV certification notices from Aurobindo Pharma Limited and Zydus Pharmaceuticals (USA) Inc., respectively, challenging the 356, 445, 061, and 738 Acetadote Patents on the basis of non-infringement.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By statute, where the Paragraph IV certification is to a patent timely listed before an Abbreviated New Drug Application (&#8220;ANDA&#8221;) is filed, a company has 45 days to institute a patent infringement lawsuit during which period the FDA may not approve another application. In addition, such a lawsuit for patent infringement filed within such 45-day period may stay, or bar, the FDA from approving another product application for two and a half years or until a district court decision that is adverse to the asserted patents, whichever is earlier.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 10, 2015, the USPTO issued U.S. Patent number 8,952,065 (the &#8220;065 Acetadote Patent&#8221;) which is assigned to Cumberland.  The claims of the 065 Acetadote Patent encompass the use of the 200 mg/ml Acetadote formulation to treat patients with acute liver failure.  The 065 Acetadote Patent is scheduled to expire in August 2025.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 30, 2015, the United States District Court for the Northern District of Illinois, Eastern Division ("District Court") ruled in favor of Cumberland in its lawsuit against Mylan for infringement of Cumberland's 445 Acetadote Patent. &#160;The opinion upheld&#160;the 445 Acetadote Patent and expressly rejected Mylan's validity challenge. &#160; The District Court ruled&#160;that Mylan is liable to Cumberland for infringement of the 445 Acetadote patent in light of Mylan's&#160;Abbreviated New Drug Application in which Mylan sought to market a generic version of Acetadote. On November 17, 2015, the District Court entered an order enjoining Mylan and its affiliates from selling or using its generic version of Acetadote until August 2025, the date of expiration of the 445 Acetadote Patent. On October 30, 2015, Mylan filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit (the &#8220;Appeals Court&#8221;).</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 3, 2016, the USPTO issued U.S. Patent number 9,327,028 (the &#8220;028 Acetadote Patent&#8221;) which is assigned to us.  The claims of the 028 Acetadote Patent encompass administration methods of acetylcysteine injection, without specification of the presence or lack of EDTA in the injection. Following its issuance, the 028 Acetadote Patent was listed in the FDA Orange Book and it is scheduled to expire in July 2031.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 26, 2017, the Appeals Court affirmed the District Court ruling in the Company's favor in its lawsuit against Mylan for infringement of the 445 Acetadote Patent. &#160;The Appeals Court opinion affirmed the District Court&#8217;s ruling upholding&#160;Cumberland's 445 Acetadote Patent and expressly rejected Mylan's validity challenge.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has additional patent applications relating to Acetadote which are pending with the USPTO and may or may not be issued.  Cumberland intends to continue to vigorously defend and protect the Company&#8217;s Acetadote product and related intellectual property rights. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cumberlanda02.gif
<TEXT>
begin 644 cumberlanda02.gif
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M.N0GG3[<XBNI?IO?*;G>*7.FMVZ[2K)#"3OK:/%-%8/E)GF=9YY5![(//C0
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M)R.J$RZ:!BN_@A.7I=PUV7G!5[(O(ZY(JV7*/+*E.&)<Z'2B0U-6/LD'UG6
M B@80>7Y,02 ",$#<)FYYYF8&H9$\11Z(0[D.="+J=Q7=;0R(L6YQ+_2M-@H
M25)CB-DX7SV^W7(W2.$$IV3!-)VQD'R\LY*LE6!4A:J1)AG'_M$W?Q;6SBY-
M3,&L$E&0+-TJ!![@1T#T8VL^T <'ULR!'[3Y_P<'\ $9&-1!JISNRM<#A)X9
M$<0^\[G/ NP8B$/@7SD.VI6J K%5K.4D^DX(Q'P&#:#Y3&D_6_HD(8;TGBU=
M:3Z#6%5ZMO2D+VTN.U^% "'V"GT9AT/# F#043Z@6N3!"$*?#R2']B*Y0OUG
M3O<YFJ5&X1T?[!$', #%UVW>%%"!V7=N !#028D/?J" 'UC;VFO6AYI_( X(
MY"S:N%4AA:F! ""8^]SH3C<5($#"*9S"W*4I+0DA@(!WG_5)[C8WNUE""@.8
M^P$DH8*_TTWP<QL  0<08 '>7?"& \$/!Q#) 1CN<(,C@ H UQ<CQ@"$4U!!
ME2^9>,>YLYK0/  (_MQN &PB]#LJV-LD#!AXQ2].C2F8) 0]X-P!0D"2+/M
M ]"KH (.,(4Y/[E3J6ASM:O]9C=S8!I0U\<!R! MEP2!'P8X1=;W88!]<-WK
M!A  UT\A]GW3!0("$$ ">J#3#9!= %/J']K3SH/(A*0  @B[ #8@K#&D_>M>
M!WS7 Y_U1@5;*P7 >M?#/OC&@WT?9!\55_ ^=LCO(^^6)_SE3\%WM?0C5 (
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M *<P!H!P@W"7+X82@R@G@>*',"'A=_Q7$L7(%6C3D0^0BA+H!=/A!=+H %0
M!!L@#S"Y0R+Q "-##=FX$HC&3%<(9VYV;>C89J3@?>U("M?V ZE -"#D$:&8
M #18$O(0*@G  PO&A*X'DB6Q 7I'>PPR=U20B!<80#R0=QK0@ !W*LSXBE59
M$@[@>I6(%?48<<T!')0G?R$1E-JQ?TD( "9)D=%E7^I"@@$)D )0B?_"%7;)
M=8E9>+ZX-6/0=7$7;5Q!E*=PF"5!B ; #[37#\='#1MP  6 E.1!*&CA  A@
M#S4B%Y9"4.)PCLK9_Y73\'0_ '7>]V8'\ -30%,R-649Z'HT^(L>P3G/-Q(
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MRZ&WXV[SEVKWGZV7[.2;TWT]>R;QRST/=JXG]*'' )\HB&6=*IM1'2R%"E,
M =2B:VKA7_E9AO(&WM %$EBN%QC2 Y\#!+ZD"PCP^(Y?;KXD?%Q/W%3@2XS/
M^)#_^)D_!L*7V#JM+1I@W;$Q!4#  PB D2%!;H_?^K[T^)B/^9#*GXUJ;K'O
M^IH_^0APNA@HB:=;&H]S'4M9;@B0_Y.2,SV1K_F=KRV;+]A0K"V3?K2M<:SF
M9JE^6FY 8/Q0@C:2" 08^+JVS_FWO_N0FL8M<1I+3B^BG H'H/?*3>I_;QS
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M^#J0P\8Z LI#K?1Z#\.?M&H.1-,HFH^\@7P0![>Y])/@!_XXF";)$:;11Q\
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M'QO'  0!*/%H&.,E/<S'QU^^#B$%2$ "#C C+T23"FD+S10$D !J.$N634S
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EENT,R5'!1LVO-'5DG#8]));2UFF4$%Y62XV/G4S60/F'@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>cumberlanda08.jpg
<TEXT>
begin 644 cumberlanda08.jpg
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MC8QEBB$X'I_A7;T4445]4< 44444444 %%%%%%%% !11111110 44444444
M%%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%
M%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11
M111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111111
M10 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4
M4444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
M%%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%
M%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11
M111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111111
M10 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4
M4444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
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MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M!11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111
M11110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111111
M0 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44
M444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444444
M44 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %
M%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%
M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M!11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111
M11110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111111
M0 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44
M444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444444
M44 %%%%%%%% !11111110 44444444 %%%%%%%% !111115FQL;C4KN"TM()
M+JYF<1Q0PH7=V)P%4#DDD\ 5[_X:^!VD?#F&/4/'B)K'B ?-'X4MIBL5N>WV
MV93D-_TQC.X<;F4Y6N#%XVC@TN=WD]HK=_\  \W9+JS:E1E6?NA114/G>:/D
M/RD'YO\ "O+_  +\)=>\>6LVHP+!I7A^U;;<Z]JDAALX3UV[\$R/Z1QAG.>%
MKM/MWA#X9\>%]+C\5:TH_P"0]XBM@T$;>MO9'*_\"F+^NU:U_&WBG4O$WV<7
MTRK:VJF*TL;:,16MK'G.R&)?E1?H.>Y->>:E]UJ\F,JN-=\0[1_E6WS>CEZ:
M1Z-/<Z91C1TAOW_R[?F2,X7W/I36!D7&2![''ZT@7'/KUIZUB>-/%6L^,-3:
M_P!<U.ZU:]("^?=2F0A1T5>RJ.RKP.E85K][\*GU+J?K4%K][\*^@IQC""C!
M62//NY:L%&.,8I6Z4+0W2NTT?O\ C7;Z-_#]*XC1^_XUV^C?P_2O!Q>S/0P^
MZ&TUJ=36KO\ 1.U>A:'_  UY[HG:O0M#_AKX+&['KP!Z9_#3WIG\->C:%U%>
MG>'ONC\:\QT+J*].\/?='XU^=Y@>U1Z#Z:U.IK5Z+H_W17:Z?]T5Q6C_ '17
M:Z?]T5^>XS<]2!4O/]6:X?Q/_J6^E=Q>?ZLUP_B?_4M]*_/#_@K%_P CI\//
M^P=<_P#HQ*^#*^\_^"L7_(Z?#S_L'7/_ *,2O@ROZMX'_P"2=POI+_TJ1^?Y
MG_O<_E^2+_P?_P"1>OO^OUO_ $7'7=UPGP?_ .1>OO\ K];_ -%QUW=%%%%?
M<GEA11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !
M11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111
M1110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
M 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444
M44444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4444444
M4 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%
M%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%
M%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !
M11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111
M1110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
M 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444
M44444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4444444
M4 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%
M%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%
M%% !11111110 44444444 %%%%%%%% !11111110 44445T7@7P'K?Q(\26V
MB>'[%KZ_GRQ&0L<2#[TDCGA$4<EF( %3?#OX>ZS\4?%EGX>T*!9[RY)9Y)#L
MAMXAR\LK?P(HY)_+)(!^T-"\'Z)\*_"I\-^&<N)0/[3UEQMGU20=_P#8A4_<
MB_%LM7S>;YQ#+TJ-+WJLMET2[OR[+=^2NUW8;#.M[TM(K^K(*;)(L2%F. /;
M-#N(U+-P*@YD8,W'HO''_P!>N2\*>$=$^"6G-;^')UU+Q--&4O?$Y0@KD8:*
MR!YCC[&3_6/_ +(.*Y/5._\ GO7;:SW^E<3JG?\ SWKY##2E4FZM1\TGNWN_
M^!V2T70];1*T59"LQD8$\#^[FGBFM3A7':M]UJY'4ONM77:M]UJY'4ONM7V&
M&V1Y5;<=Z4JTGI2K7':EU/UJ"U^]^%3ZEU/UJ"U^]^%?01^$\[H*M#=*%H;I
M7::/W_&NWT;^'Z5Q&C]_QKM]&_A^E?/XO9GHX?=#::U.IK5W^B=J]"T/^&O/
M=$[5Z%H?\-?!8W8]> /3/X:>],_AKT;0NHKT[P]]T?C7F.A=17IWA[[H_&OS
MO,#VJ/0?36IU-:O1='^Z*[73_NBN*T?[HKM=/^Z*_/<9N>I J7G^K-</XG_U
M+?2NXO/]6:X?Q/\ ZEOI7YX?\%8O^1T^'G_8.N?_ $8E?!E?>?\ P5B_Y'3X
M>?\ 8.N?_1B5\&5_5O __).X7TE_Z5(_/\S_ -[G\OR1?^#_ /R+U]_U^M_Z
M+CKNZX3X/_\ (O7W_7ZW_HN.N[HHHHK[D\L******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH *****T_#OA_4?%FNV6CZ39RW^IWTRP6]K"NYY'8X"BLRON[]D7X*CX?\
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M]=;ZE:_]=(%;_P! 9N_%:5K\9_!]TQ7^U_)8=?M%O+&/S90*^<+CK6?-U:O
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M>$9C;S-)=7H&?L\ !V\$C<QX'TY/(XY%?+%%?I[I'_!)OP1#!MU3QMK]W/\
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M#=@?.Y1Q?E&=XCZKA*CY[72::O;>WGUMVUZ'77P%?#PYYK0Z6BO(/^&@#_T
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M?_&:/^'4/PU_Z&OQ7_W^MO\ XS1_Q$;A_P#GE_X"P_LG$]E]YZ_17D'_  T
M?^@%_P"3?_V%'_#0!_Z 7_DW_P#85^6=%?J9_P .H?AK_P!#7XK_ ._UM_\
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M0_#7_H:_%?\ W^MO_C-'_$1N'_YY?^ L/[)Q/9?>>OT5Y!_PT ?^@%_Y-_\
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M(C</_P \O_ 67_9.)[+[SU^BO(/^&@#_ - +_P F_P#["C_AH _] +_R;_\
ML*_+.BOU,_X=0_#7_H:_%?\ W^MO_C-'_#J'X:_]#7XK_P"_UM_\9H_XB-P_
M_/+_ ,!8?V3B>R^\]?HKR#_AH _] +_R;_\ L*/^&@#_ - +_P F_P#["ORS
MHK]3/^'4/PU_Z&OQ7_W^MO\ XS1_PZA^&O\ T-?BO_O];?\ QFC_ (B-P_\
MSR_\!8?V3B>R^\]?HKR#_AH _P#0"_\ )O\ ^PH_X: /_0"_\F__ +"ORSHK
M]2F_X)0_#?:=OBSQ4#C@F2V(_P#1->1?%;_@E;XG\/:;<:AX$\3V_BEH\O\
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MCUS]G_[VN_\ ;#_VI7K]>0?L_P#WM=_[8?\ M2O7Z****_3CQ@HHHHK]G?\
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MG_(SY%HKZZVCT%&T>@K][**_!/\ X7M\2O\ HH?BK_P=7/\ \71_PO;XE?\
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M^AIUK_P83?\ Q53VGQ5\:V-PLUMXPUZWF7.V2+4YU8<8."'S2_XA37Z8M?\
M@+_^2#^VH?R/[SY%HKZZHP/2OWZHKX0_X)O?M0>*_B9JNN> ?&.K3Z]<65E_
M:.G:E>-ON!&KK'+%)(3F3F1&4MEA\^21@+]WU^1YUD]?(L;/ XAIN-M5LT]G
M_74]O#UXXFFJD>I\BT5ZW\9?!.G:;IEMJVG6,5LZRB&:.",+&5(.UB!P"" .
MG.X>U>25^7G_  5.^%]GX9^)WAOQE80K ?$=K+#>+&I >XMR@\PGU:.2-?\
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MG_\ DM/BW_L7S_Z4PU\7QG_R3^+_ ,/ZH]'+_P#>H!7FWQX_Y%&R_P"O]/\
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MI7_)Q^G_ /8NVO\ Z/N*_6*OR=_X*E?\G'Z?_P!B[:_^C[BOP_PU_P"1\O\
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MHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBO7OA3_P BP_\
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MSV^ZW?!.ZO2-+U2VUFR2ZM)/-A?CH05(ZJP/((/4'D54HHHJB"W11111110
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M)W_7#3__ $*XK\]Z_0C_ ()'_P#(6^)W_7#3_P#T*XKX'CS_ ))S%?\ ;O\
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MR[+'382RP@@/<2GB.%/]IVP!Z9R> 37\B<79Y5XGS54<)>5.+Y8)?:;=F_\
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MJ3U)/)))KYHKXF_X*O?\D0\*?]C%'_Z33U^6=?J9_P %7O\ DB'A3_L8H_\
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MA!S_ *%"#]0@!'US7S)172?\*U\7_P#0JZW_ ."^;_XFC_A6OB__ *%76_\
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M2&O J]]_;R_Y.T^(/_7>V_\ 22&O J_L7(/^1/@_^O</_24?!XK_ 'BIZO\
M,^HO!O\ R*.B?]>4/_H K9K&\&_\BCHG_7E#_P"@"MFBBBBO=.4********
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MGP^_Z[W/_I)-7[45_,'BE_R-Z/\ U[7_ *5,^RR;_=Y>OZ(QO&7_ "*.M_\
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MY8S(9-TH;.2 .Q]JV(?B]?KGS+&V<?[)9?ZFLI1;9O&HE&S/!?C1_P C\?\
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M!@#W/J3R3DGK7N^(O$?]GX7^R\/+]Y57O>4/_MMO2_='/E6$]I/VT]EMZ_\
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M]OKWW]@W_D[3X??]=[G_ -))J_:BOQ7_ &#?^3M/A]_UWN?_ $DFK]J*^?\
M%+_D;T?^O:_]*F=63?[O+U_1&-XR_P"11UO_ *\IO_0#7R[7U%XR_P"11UO_
M *\IO_0#7R[7Q-_P5>_Y(AX4_P"QBC_])IZ_+.OU,_X*O?\ )$/"G_8Q1_\
MI-/7Y9U^H^'/_)/T_P#%+\SQLV_WGY(]<_9_^]KO_;#_ -J5Z_7D'[/_ -[7
M?^V'_M2O7Z****_3CQ@HHHHK]G?^">__ ":!X _[B'_IPN:_&*OV=_X)[_\
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M\/SZYXENI[/2X1F2Y@LI[D)[MY2,0/K7YI_M@?M_2?&C0;CP7X&L[K2?"T[
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M'JL<:*WZR+^=?FC7T?\ MS_M#6GQ_P#C SZ+,\WA;0838:;(PP+AMV9;@#J
M[8 SU6-"0"2!\X5_77!V75LKR/#X>NK3U;7;F;=O5)J_F?#8^K&MB)2CL>L?
ML_$_\3T8QQ;G])*]@KF/ASX7?PGX8AM9AB[E8SSC.0KD ;?P 4<=2">]=/11
M117V9YX4445W/P)_Y+=\//\ L8M/_P#2F.OWLK\$_@3_ ,EN^'G_ &,6G_\
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M2T^+?^Q?/_I3#7Q#7V]_P2?_ .2T^+?^Q?/_ *4PU\7QG_R3^+_P_JCT<O\
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M9?\ (HZW_P!>4W_H!KY=KZB\9?\ (HZW_P!>4W_H!KY=KYJ_X*,?\FE^+/\
MKO8_^E<5?C?7[(?\%&/^32_%G_7>Q_\ 2N*OQOK]!\,/^1)4_P"ODO\ TF!Y
M><_[Q'_"OS9Z'\"?^1NNO^O-_P#T8E>\5X/\"?\ D;KK_KS?_P!&)7O%%%%%
M?KQX(44444444 %%%%%%%% !11171?#W5FT'Q_X9U--P:SU.UN1MZY256X]^
M*_H#K^?WX=Z6VO>/O#.F*&)O-3M;<!2,_/*J\9[\U_0%7\[^*_+[;!VWM/\
M.-OU/J\EOR3^0C=#7R+7UT>AKY%K@?V@K)=2^ OQ'M6('G>'-13<PS@_99,-
M^!Q7X,5^]?Q\NELO@7\1KAPS+#X<U*0A>N!:R'BOP4KU?"J_U3%=N:/Y'/G7
MQP]#8\#W$EKXRT22&3RV-W&GRG VLZJR_BI-?4=?+'@TG_A+M$&0O^FP#)Z'
M]XO]!7U/11117[F?.!11111110 44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%;FFZ6FJ>&=0DBB7[792K+OSRT95MR_AMW?G0,***P-2U>XTWQ
M9I=NP)TZ\MYE=N,1S*\0C_[Z#L/J%K#HHHH$;]%%%%%%% !11111110 4444
M4444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
M %%%%%%%% !11111110 44444444 %%%%*K%&#*2K#D$=:UK3Q?K5DP:+4[D
MX& LCF1?R;(K(HH 0@,,$9%<WK'PU\)^(-YU'PYI=T[\M(]HF\^^X#.?QKI:
M*[.Q^*VL6VT3I;W8[LR;6/\ WR0/TKH;'XOV4O%Y8S0'L86$@_7%>5T5/*BN
M:2ZGDNI?LP>!KS<UG:W6D2$YW6ERQ&?]U]PKG;K]FW4-,8MI&L6]VN?EBO8V
MB('^^N[)_P" BO?**]XL/%6D:P0MK?PO(3M$;G8Y/L&P3^%6[@%<YS^-?/E:
MVE^+-6T=0EM>R"(<>5)\Z8] #G'X5')V-E5[H^;IO">N>&Y#_:6CW44(.!<0
M)Y\>.[9CW;1_OA:UM'FCNHQ)#(DR9^\C _RKWNL?5O".D:W(9;NQC:?_ )^(
M\QR_]]KAOUKUVX[UDW?>L+3?B5!<;8]2M3 QX\ZVY7\4/./H?PK<::+4+<W%
MG,EW!QEHCG;Z;AU'XBDDT]1RDI+0X33_ .&MZU^Z*CNO U_I[;]-O$O8L\V]
M]\K]><2J.PZ!E.?[PZU#:7PBFCM;R&73[Q_NP70"EN,G:P)5_P#@).*PKU<Y
M!K'\16O]J69U)!FZ@VI=<_?7@+)]>BG_ (">YK8O#GD5F07GV&Z$I7S(R"DL
M9Z.A&&7\1^N*Z+71Y*GRS\F;]M1H['1;_P#L]C_H=P6DM-Q_U;<EXOIU91S@
M;AP%446_%3WUB-0LVA#>5)P\4F,F-P<JV/8@&N3HJ[K.F_V7J$D"OYD6 \4F
M/OHPRI_(\^^:I5)VFS15/2=0_M.P2=HS%+EDEC/\#J2K#W&0<'N,'O5RBBBB
M@ HHHHHHHH ****^WO\ @D__ ,EI\6_]B^?_ $IAK]1Z_+C_ ()/_P#):?%O
M_8OG_P!*8:_4>OY*\1O^2@J?X8_D?<Y5_NJ^9YM\>/\ D4;+_K_3_P!%R5X;
M7N7QX_Y%&R_Z_P!/_1<E>&U^?O\ P5O_ .0#\-/^OF__ /0(*_-ROTC_ ."M
M_P#R ?AI_P!?-_\ ^@05^;E?N/A__P DYA_6?_I<CYS-/]ZE\OR/7/V?_P#F
M._\ ;#_VI7K]>0?L_P#_ #'?^V'_ +4KU^BBBBOT0\D******** "BBBBM_P
MGX$\2^/+J:T\,^'M4\17<*>=+;Z38R74D:9 W,L:DA<D#)XY%8%?;W_!)_\
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MW_)PWQ2_[&G5/_2N6ORSPJ_WW$_X5^9[.=?PX>IX97U'X/\ ^11T3_KQ@_\
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M?^11T/\ Z\8/_1:UL44445WF04445^K/_!*?_DWCQ!_V--Q_Z26E?9E?&?\
MP2G_ .3>/$'_ &--Q_Z26E?9E?Q;QA_R/\7_ (OT1^@X#_=H>AX1\=_^1NM?
M^O!/_1DE>=UZ)\=_^1NM?^O!/_1DE>=U^0__  4R_P"3HKW_ +!5G_Z"U?*5
M?5O_  4R_P"3HKW_ +!5G_Z"U?*5?U5PM_R(\'_U[C^1\7C?]YGZGT7\(_\
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M3_Z!7_DQ+_\ %5K^#?\ D4=$_P"O*'_T 5LU]-#_ (*.?';/_(SV7_@IMO\
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M^V:*]S_7+B#_ *"Y?A_D<_U##?R(]<_X: /_ $ O_)O_ .PH_P"&@#_T O\
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MDT^1;75RL9)"Q7PXBEST#?W'[8/!XP<G:.;HHHH-3?HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBIK.
M\GT^=9K::2"5>CQL5-0T4 %0WEG;ZA;M!=01W$#?>CE4,I_ U-1766?BJWU)
M?+U)5MKCM>0K\K'_ &T'X_,OY4FIV<MFP$B@JXW)(IRCKZJPX(KE*U='UPV*
MM:W*FYT^0Y>'/*'^^A[-^AZ&FG8QJ4U/7J<W-H=YHYWZ<[7MJ/O6=Q)F11_T
MSD/7_=<\Y^\H%7-/OH-0C9H6)*':Z,"KHV,[64\@_6MBLW4M'%U,MW;O]FOT
M7:LP&0Z]=CC^)?U&3@C)JU?)_:&A!^#-8-M/J87/'_?+_P#H?M6!766MDMOJ
M4$/F^=8:E&8([C;PVX8&1V96VY'8C\:Y1E,;%6!5E."#U%(TC>UF06X_L_7&
MQQ#?KGJ !,@Q]260?@(O>MFN=N=0:;2YYFA:&^T]A-);CYV&TY.WID.NX ^_
M0$$#H58, 0<@\BDHHHH*%HHHHHHHH ****^U/^"4UZ8_CUXCM25"3>&YGYX)
M9;JVP!^#$_A7ZHU^*_[#OQ-@^%O[2GA6_O[G[)I6HO)I5W(3A0LZ[8RQ) "B
M41,2>@4U^U%?ROXF8:='.E6:]V<%9^ET_P!/O1]ID\E+#\O9GG7QTAED\&P-
M'&SK'>(TA49VKM<9/MDK^=>$U]-?$#1Y=>\':I909,S1;T54#%RA#[0"1R=N
M/;.:^9:^!?\ @K'I]S?:%\-OLUO+.5N;[=Y49;;E(.N*_.7_ (1_5/\ H&WG
M_@.W^%?T*45?#_B#+(LNIY>L-S\M]>>U[MO;E??N&*RM8FJZKG:_D>N?L_GG
M7>W%N>3R1^\YQ7KV:^1:*_GK_P"$?U3_ *!MY_X#M_A1_P (_JG_ $#;S_P'
M;_"OZ%**^A_XBQ/_ * E_P"!_P#VAR_V(O\ GY^'_!/KK-&:^1:*_GK_ .$?
MU3_H&WG_ (#M_A1_PC^J?] V\_\  =O\*_H4HH_XBQ/_ * E_P"!_P#V@?V(
MO^?GX?\ !/KK-&:^1:*_GK_X1_5/^@;>?^ [?X5]K_\ !*K2[RQ^,OBUKBUF
MMU.@$!IHV4$_:(>.17Z>T5XN<^(TLWR^K@7A>7G5K\][:WVY5^9T8?*E0JQJ
M<][>7_!/KK-><?'C'_"(V?&?].3C.#_JY.E>&445^>__  5PND33?AA;<^8\
MNHR>V%6V'/XM_.OT(K\F_P#@IM\4+;QO\=K7P[87(N;3PM8_99BO*B[D;?*
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M=[;_ -)(:\"KWW]O+_D[3X@_]=[;_P!)(:\"K^Q<@_Y$^#_Z]P_])1\'BO\
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MZ_\ A']4_P"@;>?^ [?X4?\ "/ZI_P! V\_\!V_PK^A2BC_B+$_^@)?^!_\
MV@?V(O\ GY^'_!/KK-&:^1:*_GK_ .$?U3_H&WG_ (#M_A1_PC^J?] V\_\
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M_I3#7QW&?_)/XO\ P_JCT,O_ -Z@%>;?'C_D4;+_ *_T_P#1<E>DUYM\>/\
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MX!L_&EG\W^CZC&I$-TH.1WVMCJN?R_$@_.VK:3=Z'J$MC?1>3<1D@JPSG/\
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M#IR6QZ117CT-]?Z"P_LN_EM8EQ_HK8D@('1=C?='^X5K5L/B]/:@)JVE^9C
M^T:<X(8]SY;D%?H&8UYU170:AX#US3<EK%YT!P'M_P!YGWP.?S%8,D;1.R.K
M(ZG!5A@BJ,]5N>F45R^F_$SPSJC*B:O!;S-TBNSY+'Z!\9_#-=.K!E#*0P/(
M(IM%%%,0M%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444
M444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444
M%%%%%%%% !1116MH=^JEK"YD*6=PP(?_ )XR?PR#TQT/MGT%.\7VK6GB.]5U
M*/(PF93_  EP'(_ L1^%8]7]6U>36&M7E0"2&!8&<$DOMSAC[XP/PI=1F9K%
MF_R7MLF^ZMP?W8Q^^C_BC/UZC_: YP3F'P?>07WANR>VE\^WC4P)-NW>8L;%
M V??;G\:V:SM$T.#08KJ*V+"&>YDNA&<81I&W.![%RS?\"JA1113$:-%%%%%
M%% !11117VS\!/\ @IEXF^'NBV>@^.-(/C'3K9%AAU**<17\<:C #D@K,0
M"=K'JS,:^)J*\;-,GP.=4?88ZDII;=&O1K5?KU.BCB*F'ES4W8*\_P#%_P '
M=.\27K7MK<-IMU(^^7">9&Y_B;;D88\<@XXZ9)->@45^M6D_\%0O@YJ0_P!(
MM_$NEG&?])T^-N?3]W*U:/\ P\N^"7_00UC_ ,%;_P"-?D)17P,O#/(I.Z<U
M_P!O+]8GJ+.,2NB^[_@GA4GP)UU9#LO=/==QP7=P<=N-AY-)_P *)U[_ )^]
M/_[^R?\ QNO=J*_7O_AY=\$O^@AK'_@K?_&C_AY=\$O^@AK'_@K?_&OR$HJ?
M^(9Y'_-4_P# E_\ (A_;&([+[O\ @GA/_"B=>_Y^]/\ ^_LG_P ;H_X43KW_
M #]Z?_W]D_\ C=>[45^O?_#R[X)?]!#6/_!6_P#C1_P\N^"7_00UC_P5O_C7
MY"44?\0SR/\ FJ?^!+_Y$/[8Q'9?=_P3PG_A1.O?\_>G_P#?V3_XW1_PHG7O
M^?O3_P#O[)_\;KW:BOU[_P"'EWP2_P"@AK'_ (*W_P :IZG_ ,%/?@S8Q[H5
M\1:DW/R6VG*#_P"1)%'-?DA13CX9Y&G=N;_[>7_R(/.,3V7W?\$\)_X43KW_
M #]Z?_W]D_\ C=(OP(U[_GZTU?I+)^!^YGBO=Z*^^/C-_P %3-7\0:;=:9\.
M?#S^'O.4H-:U1UEN44CDI$H*(W^TS./;/-?"-[>SZC=SW5U/)<W,SM)+-*Y9
MW<DDLQ/)))R2>2:JT5]YE.1Y?D=-T\!2Y;[O=OU;U^6W8\ROB*N(=ZCN>;^&
M?@EINCW:W.H7!U5E(986B"1Y'=AD[L>F0/:O2*******]PY@HHHHHHHH ***
M*^V?@)_P4R\3_#W1[/0?'&D?\)CIEM&L,.I13>3?QQC@"0D%9L   G:W<LQK
MZ1TG_@J%\'-2'^D6_B72SC/^DZ?&W/I^[E:OR5HK\\S#@+(LPJNLZ3A)[\KL
MONU2^21ZM+,\327+>_J>?^,/@[IWB2]:]M;AM,NY'WRX3S(G/.6VY&&)P<@X
M.#D$DFN*D^!.NK(=E[I[KN."[N#CMQL/)KW6BOU[_P"'EWP2_P"@AK'_ (*W
M_P :/^'EWP2_Z"&L?^"M_P#&OR$HKR?^(9Y'_-4_\"7_ ,B;_P!L8CLON_X)
MX3_PHG7O^?O3_P#O[)_\;H_X43KW_/WI_P#W]D_^-U[M17Z]_P##R[X)?]!#
M6/\ P5O_ (T?\/+O@E_T$-8_\%;_ .-?D)11_P 0SR/^:I_X$O\ Y$/[8Q'9
M?=_P3PG_ (43KW_/WI__ ']D_P#C='_"B=>_Y^]/_P"_LG_QNO=J*_7O_AY=
M\$O^@AK'_@K?_&C_ (>7?!+_ *"&L?\ @K?_ !K\A**/^(9Y'_-4_P# E_\
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MZQ^RU\1-'^$WQ\\)>+?$#S1Z/ILLSW#6\?F. T$D8PO?EQ7Z1_\ #R[X)?\
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M_FJ?^!+_ .1#^V,1V7W?\$\)_P"%$Z]_S]Z?_P!_9/\ XW1_PHG7O^?O3_\
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M\$O^@AK'_@K?_&C_ (>7?!+_ *"&L?\ @K?_ !K\A**/^(9Y'_-4_P# E_\
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MI_\ W]D_^-U[M17Z]_\ #R[X)?\ 00UC_P %;_XT?\/+O@E_T$-8_P#!6_\
MC7Y"45\O_P 0SR/^:I_X$O\ Y$[/[8Q'9?=_P3PG_A1.O?\ /WI__?V3_P"-
MT?\ "B=>_P"?O3_^_LG_ ,;KW:BOU[_X>7?!+_H(:Q_X*W_QH_X>7?!+_H(:
MQ_X*W_QK\A**/^(9Y'_-4_\  E_\B']L8CLON_X)X3_PHG7O^?O3_P#O[)_\
M;H_X43KW_/WI_P#W]D_^-U[M17Z]_P##R[X)?]!#6/\ P5O_ (T?\/+O@E_T
M$-8_\%;_ .-?D)11_P 0SR/^:I_X$O\ Y$/[8Q'9?=_P3PG_ (43KW_/WI__
M ']D_P#C='_"B=>_Y^]/_P"_LG_QNO=J*_7O_AY=\$O^@AK'_@K?_&C_ (>7
M?!+_ *"&L?\ @K?_ !K\A**/^(9Y'_-4_P# E_\ (A_;&([+[O\ @GA/_"B=
M>_Y^]/\ ^_LG_P ;H_X43KW_ #]Z?_W]D_\ C=>[45^C_P"UM^W#\+OC!^S[
MXK\(^'+O4I=:U'[)Y"W%BT<9\N[AE;+$\?*C5^<%%%?<9'D>$X?PTL+@V^5R
M<O>=W=I+LNR/.Q.)GBIJ<][6T/)O _PFU?PSXJL-2N;FRDM[?S-RQ.Y<[D90
M "H'4C\J]9HHJ2%%>2-7D$:%@&8@G:/7 K]3?A7^W5\ /A'\.] \(:1>:Q]A
MTFU6 .-*93*_621@#C<[EW/NU?E=16.?</83B*G"EC)248.]HM+7:[T>W3U9
M6&Q4\*W*"5WW"O'?%/PG\1^)M?O-2DN]/7SG^13*_P B#A1]SJ %_'/K7L5%
M?KK??\%-/@S!8W$UO<ZS=7$<;-';KIS(9& X7<3@9/&37Y4^./&6H_$+QAK?
MB76)!+J>K7<EY.RYVAG8L54$G"C. .P %8%%89#PME_#LJD\&FW.R;DT]%T6
MB^96)QM7%)*IT['A</P&UHS1K+>6"PEL.Z.Y8 GD@; "?8D"O;K.TBT^S@M8
M$V00HL<:Y)PH& ,GKP*FHHHHHKZXX HHHHHHHH ******** "BBBBBBB@ HH
MHK]#?V/_ -OSPI\./@]9^$OB%<Z@+W1Y6@L+BUMFG$EH?F16(/!0EE';:$ Z
M&O;O^'EWP2_Z"&L?^"M_\:_(2BOS/&^'N2X[$U,5/G3F[M)I*[WLK,]BGFN(
MIP4%9V_KN>8_$3X3W7BC71J6FSVT+2H!/'<%QE@,!@0#U4*,<#Y0>]<O_P *
M)U[_ )^]/_[^R?\ QNO=J*^H/VYOBE\,/C;XRTKQAX"GO/[9FA-MJ\=U9F!9
M0@ AE!/5MN4/LJ>E?+]%%?=9;@*>5X2G@Z4FXP5ES.[MVV6VR\CS:U5UINI)
M:OL<I\.O#^K>%]$;3=3EMYXXG+6[P.6(4\E3E1WR<Y/WB.,#/5T445]-_L'_
M !Y\*_L__$C7]9\72W<-E>Z4;.)K6W,S>89HWP0#P,*W-?,E%/,<!1S3"5,%
MB+\DU9VW_4*-65&HJD=T%<G\2O"=YXQT."RLI88I([E96\\D*5"L". ?[P[=
MJZRBOU[_ .'EWP2_Z"&L?^"M_P#&OA7]NWXX>%_C]\6](\0^$9KJ?3K;0X;"
M1KJ PMYJW%PY ![;9$Y^M?-U%?)Y-P7EF1XM8S"N?.DUJTUK\D=N(S"MB8>S
MFE8\)_X43KW_ #]Z?_W]D_\ C=>D_#7PG>>#="GLKV2"622Y:93 20%*H,$D
M#)RI[=ZZVBBBBBOO3S HHHHHHHH ******** "BBBBOHK]D7]KK6OV;O$PM+
MLS:KX&U"4'4=*5LM$QX^T09X$@&,KT<#!P0K+\ZT5Y^/P&&S/#3PF+AS0ENO
MU79KH^AK2JSHS4X.S05S'CKP+:^-+!59A;W\(/D7.W.W.,JPSRIP/IU%=/17
MZ]_\/+O@E_T$-8_\%;_XU\%_MQ_&KPS\>/C%:>(_"DES-ID6DP6;/=0&%C(L
MDK'Y3VPXYKYXHKY/)>"\LR+%?7,(Y\UFM6FM?DCNQ&85L3#V<[6/"?\ A1.O
M?\_>G_\ ?V3_ .-UZQX%T&X\,^%[/3;IXY)H=^6B8LO+LPP2 >A':MZBBBBB
MOO#S HHHHHHHH ****]8_9:^(FC_  F^/GA+Q;X@>:/1]-EF>X:WC\QP&@DC
M&%[\N*_2/_AY=\$O^@AK'_@K?_&OR$HKXG/.$,NX@Q$<3C')2BN7W6DK7;[/
MN>EAL?5PL'"G:V^IG^(-/DU;0=1LHBHEN;>2%3)G:"RD#..W->,_\*)U[_G[
MT_\ [^R?_&Z]VHK]>_\ AY=\$O\ H(:Q_P""M_\ &C_AY=\$O^@AK'_@K?\
MQK\A**^<_P"(9Y'_ #5/_ E_\B=7]L8CLON_X)X3_P *)U[_ )^]/_[^R?\
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M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
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MRE6I4WRSFD_4M1D]4@HI,T9KFZ*Z3_A6OB__ *%76_\ P7S?_$T?\*U\7_\
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M\8O^/K3/]R3^:UYW6\=CFJ?$>V? /_D"ZO\ ]?8_]%K7J5>6_ /_ ) NK_\
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M-]S7S_$7_(EQO_7JI_Z0SJPO^\4_5?F%<A\6O^2?ZK_VR_\ 1J5U]<A\6O\
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M)R,'S"<.,$'&22#D<#!]3HHHHHHKZ,Y HHHHHHHH ****^\?^"2__)0O'O\
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M9'_8/UCX]P0>)_$UQ/X>\#ESY3Q*/M6HX."(=P(1,Y!D(// 4\D?5WC7XZ?
M#]A^&;P]X3\.6M]XKB0QRV6D*KW"GD[;N[?++S_#EV&1\@!%;7[<W[07_#-_
MPCTSP]X1\O2_$&M(UCIOV= JV%K$BK)(@ PI4,B(.,;LC[F*_(B::2ZFDEED
M:21V+LSDLS,3DDGN:_'\LP6,XYOF.:5)0PMVH4HNRE;K)]>U]V[VLM_?K5*>
M6_NJ"O/JV87C[XF6G@^.2U@VW6K%,K"3\D6>C28Y QDX')QVSFN+L_#GC#XG
M(MWJ>H-IVD3C<B@D*Z$DJ4B4C(!QR_."I!.*I?"WPLWC37[S6-8!NK:&3>1)
MG;-,3GGC:P'7 QCY>H)KW6OMKQ-_P5<^(5]=N=!\*>'-(LS]U+P3W<H_X&)(
MU/\ WQ4'AW_@JQ\2;+4(WUGPUX:U6QS\\-M'/;2G_=?S' _%#7Q/17V_^IO#
MZA[/ZI&WSO\ ?>_XGG?VABKWYSS^Q^!_AVUD#SM>7WRX*32A5^OR@']:DU#X
M*>&KQ5$,=U8D=?)G)W?7?N_3%=[17ZZ?#?\ :,^"G[;FFCPEXIT&WM]=:)F7
M1=<56<G;EVM+A<'<!GE=DF QQ@$U^>/[4WPW\ _#+XH7.E?#SQ;'XGT;;ODC
M4F4V,N?FA,P&R4#J&7D?=;E<GQG-%9Y-PO#(L7.K@Z\U1:_A/6*?>[U]-GW;
M6@\1C7B::C."YN_]?UY'B&H>"?%?PZD%UHE]->V2MO9;?(YP%^>$DALYZ\XV
MYXP*]8\+ZCJ.J:/#<:II_P#9MVW6+<#D8!W8SE<_W3R*UZ*****^W/-"BBBB
MBBB@ HHHHHHH H ****]W_8V^ ,G[0'QFT_3;J%V\-:;B_UB4 [3"I&V'/K(
MV%QG.W>1]VOUZN_%G@WQ5XHUOX6W,UM=ZDNCK/>Z.V-K64VZ(K@>V-R]A+'_
M 'A7AO[-_P /](_8O_9;U#Q1XJB^RZO-;?VQK;859=Y7$%F"<?,N]4"DX\R1
M\'#5^<W@[]ICQ%X?_:1B^+EX[76HW&HM<7ULCG;+;2?(]NN3PHB.Q,Y"[4/\
M-?S_ )AA,1QYCL56PTVJ6&3C2?253?\ &V_1<K/J*52.6TX1FO>GJ_)?U^I@
M^-O%$?A'P[<7[ --_JX$(R&D/W0>1QW/L#7S\FFZWINGVOBM&8))=,5N2P9_
M-!)W'/4$@C)SDJ<\$9ZGQMJ#_$KX@6FCV4H^R0,;='&.N0TLHZ9&%Z9.0F1U
MKV#4O#-GJ'AJ31-GEV9@$"#EMF -IYZD$ \^E97[2'P5O_@#\7=:\)W6^6TC
M?[3IUTX_X^+1R3&_U&"I_P!I&%>75^LW[>GP9L?V@O@/I_C_ ,+%=0U+1+3^
MU;.:!<_;-/D17D4>I"[91_NLH&7K\F:_3>$\\_MS+8U:O\6'NS7]Y=;>>_K=
M=#Q\=A_J]9I?"]4/\-Z]!XFT2UU& ;5F3+1YR8W'#*3WP<C/?&:TZ\3^%>N3
M^$?%5WX;U%Q'%-*4&X_*LXX!!)'# 8'4D[<=Z]LHHHHK[,\\******** "BB
MBBND^&__ "47PM_V%;7_ -')7-UTGPW_ .2B^%O^PK:_^CDKGQ'\"?H_R-*?
MQKU"DI:2OU$_X*C?\FUVG_8P6O\ Z*GK\EZ_6C_@J-_R;7:?]C!:_P#HJ>OR
M7K\R\-?^1%_V_+]#ULW_ -Y^2/"O@7_R.%U_UX/_ .C(Z]VKPGX%_P#(X77_
M %X/_P"C(Z]VHHHHK]5/%"BBBBBBB@ HHHHHHHH ****Z/X>^!]2^)7C;1/"
MVCQK)J>K726D._(5"QP68@'"J,L3V -?K%I_@OX2?\$^?A*/$5W9_;=6^6W?
M53 KZCJ5RP)\N+<<1K@,=H(4*F26;EOSS_87U^Q\-?M7?#Z\U&58+=[F>T5V
MZ>9/;30Q#\9)$'XU]U?\%+/@WXE^)WPOT+5O#5I<:J_AZ[EEN]-MD+R/#(B@
MRJHY8H4' !.'8]%-?B_&6(EB\[P638FJZ>&FKR:=N9WDK-_)+_MZ_8^AR^/)
MAJE>"O-;?@0WEY%I]G/=3ML@@C:61@"<*HR3@<G@=J\.;5-?^,&NM8P.UGI*
MMF1%.8HTR.7QC>V5&%/?., ''JWQ!L;C4O!FK06Q83&+> N<L%(9E&.[ $?C
M7F'P-\066FZGJ%C<RK!+>B,PLY"AF5F&WDYW$N/\XS\]^*O^"K7Q"OM0<^'O
M"_A[1[#/R17JS7<P^LBO&I_[X%:'P_\ ^"K?BZSU2-?&GA/1]4TQF57?1_,M
M;A 3RPWNZO@=%^7/]X5\($45]G+@OA^5+V7U2-OG?[[W_$\]9CBK\W.=?I/P
M1\/V,:_:_M&HR; K>9(43=CEE"X(S[DU'K'P/T6\5S83W&FRX 4;O-CR.Y5N
M22/]JO1:*_0+]M;XX?L[?%;P#;:AIEB^M>/]0MEGL[W2X1;3V9(P%O9"N'"X
M(\KYSQP4#!Z_/VBBO7R7)Z61X582C.4HIW]YWMY+HEY(PQ&(EB9\\DD_(\Y^
M&OAWQ=H%Y);ZG=)_9,*E%CD?S2Y' :/G*KQWQ_N]QZ-1111117O'*%%%%%%%
M% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1
M1111110 44444444 %%%%%%%% !1115S3-8O=&F\VRN9+=^^T\-]1T/XUW.C
M_%R1,)J=IY@_YZVW!_%2<'\Q7G5%*R92DUL9?B'PQI/BS3VLM9TZWU*U;_EG
M<1AL'U!Z@^XYKPOQI^QYH]\TEQX8U*729CDBUNOWL/3H&^^O/.3N^E?1%%>]
M:1XNTG6]JVUY'YK<"&0['SC. #U_#-;%?-M:VF^+-7TA0MK?S)&HP(W.] /8
M-D#\*CE[&BJ=SX,\4?!#QIX):1[[1IKNU4G_ $RQ'VB+ &=Y"_,H'JRBN5A^
M_7Z.USWB'X?>&_%>YM6T2SO)6&#,\0$G_?8PWZU[ZO6G5Y/8_%Z_AP+NS@N1
MCK&3&?ZC]*Z"Q^+6DS[%N(;BU8_>8J'0?B#D_E4\K-%.)\*P?PU=AKZ7UK]E
MOPY=^8^EW]]I4A&$1F%Q$I]<,-__ (^*XO4_V8/$=G(?[/U+3M0BQG=*7@?/
M^[AP?^^Q7<4C5B6?CC0K[/EZG N/^>Q,7_H6*T[?4+6^7=;W,-P/6*0-_(U%
MF6FCRR'O6C;]_K6_=?"'QEI:L9_#URR#H]N\<W_CJ.Q_2L^;P_JVFX^V:3?V
MH P3-:RHI/U*U-12TE# (:T(:S3/';\2LL3?[7RU>AGA/22/_OH5YC\8O^/K
M3/\ <D_FM>=UZ;\7;&XFN-+:."1DV2#<JDCJO>O/X]&U";[EA=/Z[86/]*UC
M**6K.>:;D['N'P#_ .0+J_\ U]C_ -%K7J5>6_ /']CZUC!'VU<$8Y_=)S7J
M54J*U[7PGKE\Y6WT;4+AAR1%:R,1^0K6L?A-XXU+;]C\&Z_<[SM7R=+G?<?0
M82HEB*,/BFE\T2H2>R"BDS1N ZG%<E17H]G^SC\5+YOW7PX\4[?[\FD3QK_W
MTR@?K6O;_LF_%60;I?"OV$?]1'4+2U_]&RK7)+-,!#XL1!?]O1_S-%0JRV@_
MN8M%0M>0)($:>-7_ +I<9_*GM,BH6SD=?E!/\J\AHKVV#]DWQ8JYU/6?"^CC
MOYVKI<8_\!Q+4J_LYZ-IXSK/Q%T]<=5T;2[FZ/\ Y%6 ?K6']L8'[-3F_P *
M<O\ TE,OZK6_EMZZ?F/HJ-9E9<C/X@C^="R[ESM(]CBO#:*]JN/ ?PRT-!Y]
M[XJ\0/W,$=MIR_\ CQG-8]YXP\&^'Y/^)5\.+*Y<<+)KFIW%T>G4K$8E_2M8
MX_VO\*E*7W+_ -*:?X$NER_%)+^O*Y)13-Q]A2\^M>6\UVWAGX+>.?%UJMUI
MGA;49-/;_F(W$7V>S'UGDVQC\6K;L_CEXIMI,:(NE>%UZ#^P=*MK:4?]M@AD
M_P#'ZEF\1:OXGO/M>M:K?ZO=][C4+AYY/^^F)J*M;&):1C'U;E^%H_FPC&EW
M;_#_ #_(=36=5."1GKCO05^II-H7@# ]*T],_9YM+-U;Q/XXT?3SP6LM'#:I
M<CVRF(?RE-=[X<\"_#GP[,CV'AJY\27"G(NO$US^[![$6T.T?@[N/:N2TGM7
M9Z1]X5\QC*V)GI4JOT7NK\-?O;/4ITZ<=8Q_4/,XR ?Y4UF;UQ]*5NE(W>O2
M8_$^H:E80V#3);:7%S%IMA$EM:1_[L,85!]<9K?T?[HKC-'^ZM=IH_\ 6OA\
M3&,$U%6/1IMMZC%4+]>F2<FG=S2+2]S79Z7T6I_B7\4K7X+_  UU/Q7/L>]C
M_P!&TFW?!^T7K E.#U5/]8WLFWJPIFBQHWFR33PV5I!$]Q<W<QVQ6\*#<\KG
MLJ@9KX4_:7^-S_&;QPK6!DB\+:0C6ND6T@PQ0G+SN/\ GI*PW'T 5?X:YLHR
M=YQC53DOW<=9>G2/K+\KOL:XG%+#4KKXGM_G\AW\-0RKYW[D'AOO_P"[_P#7
MZ?\ ZJD9MJDXW'L!WI88?+W,22[G+9.?P'H/\]Z\IU#4+G5KZYO;R>2YN[F1
MIIII&RTCL<LQ/<DDFJE%%?O^B5D?&DM%%%%%%% !11111110 44445TGPW_Y
M*+X6_P"PK:_^CDKFZZ3X;_\ )1?"W_85M?\ T<E<^(_@3]'^1I3^->H4E+25
M^U?[2FA_##Q!\/(;7XM7,-IX6^WQNDD]S) /M 5]@W1D-T+<=*^6O^%9_L-_
M]!K3O_!W>_\ Q==]_P %1O\ DVNT_P"Q@M?_ $5/7Y+U^!\$Y!5S+*O;PQM6
MDN:2Y82M'IK;N?39ABHT:W*Z<9:=4?-WPVNM<L]<N)/#]E#?7?V9@\4Q"C9N
M3)R649R!WKTK^V_B7_T+^G?]_%_^.UR/P+_Y'"Z_Z\'_ /1D=>[5^G>B>+?V
M(?A-=&^TN'2+Z^A.4\RSOM38NN,,AF5T4YP000.X->?_ +1'_!3BX\4:'=^'
M_A?IEYH4-S&89M?U#:MTJ'AA!&C,(R>TA8L 3@*V"/@2BOT/#\$9=&O'$XVI
M4Q$X[>TES+[K+[G='E2S*KRN%-*"?96/(9;'XH:VS6\T_P#9T,S$LZO"BQCK
M@-&3)C/ QD^M:?@OX.0Z+>)J&KW*W]XK^8L48/E*P)P23RW;'  /8\&O2Z**
M***_03R@HHHHHHHH *****^BO^">_P#R=YX!^M__ .F^YKYUKZ*_X)[_ /)W
MG@'ZW_\ Z;[FOG^(O^1+C?\ KU4_](9U87_>*?JOS"N0^+7_ "3_ %7_ +9?
M^C4KKZY#XM?\D_U7_ME_Z-2OT5_:MO?@!:7GAH?&Y(6G9+C^RO-@O9/ES'YO
M_'LIQSY?WOP[UX'_ &Y^P5_SRL__  "UK_XBL3_@KA_R%OAC_P!<-0_]"MZ_
M/>OR[A/AB.89+0Q+QE>GS<WNPJ<L5:4EHN5VVN_.Y[6.QCI8B4/9Q=K;K79'
ME?@/_A-?[)F/AHL;+SCYF# ?WFT?\]#G[NW]*Z/_ (NO_M?^2E;'P(_Y%2^_
MZ_F_]%QUZ17Z1_VY^P5_SRL__ +6O_B*/[<_8*_YY6?_ (!:U_\ $5^;E%?6
M_P"ID/\ H88G_P &_P#VIP_V@_\ GU#[O^">/_\ %U_]K_R4H_XNO_M?^2E>
MP45^VOQ@;0'_ &+_ !.WA3 \+-X)D.E;0X'V/['^XX?YQ^[V?>Y]>:_$JOV0
MU;_E'/'_ -DTA_\ 3<M?C?7@^'$/9T<;"[=JK5WN].OF=.;.[IOR/GOX??:?
M^%K6XU#/V\7%SYV2&_>;'W<CCKGI^'%?0E>#>&/^2Y3?]?\ >?\ H,E>\T44
M45^Q'@!11111110 44445]Z?\$Q/V>_[?\27GQ3UFWS8:2S6>CK(.)+HKB28
M#N$1MH/3<Y(Y2OC3X9_#_5?BIX\T/PEHD?F:EJUPMO'D$K&.2\C8_A10S$^B
MFOVUTBR\#?LZ?"[0_"T_B/3O".BVEO\ 8+6]U2\@M6EEVDO(&DPC2LQ>0\8W
M$G&*_)_$'.YX/!K+,+K5KZ.VZAUV_FV].8]S*\.JE3VT_AC^?_ "O-_C5XL_
MLK14TFW<K=7W,FTX*P@\]_XCQT(*AQQ7H-]?0Z;93W=P_EP0(9)&P3A0,G@=
M:^:[R^U3QAXDN-8ATRXU*195D-NL+3(B9/EQN$'3  [9Y-?G%_P4B^/1^)7Q
M<'@W2[KS/#_A,M!((S\DU^W$['UV8$0ST*R8X:OCZOTFF_9/_9'N)'DF^,%M
M-+(Q9Y'\8Z>69B<DDE>2:9_PR/\ LA_]%=M/_"PT_P#^)J<IXGRG*,#2P-"C
M5M!6O[-ZOJ_F[L=?!UZ]1U)2CKYGLGPF\)_\(WX=%Q/&4OK[;)*&/*H,^6OX
M D^N6([5V]>/+\1/'_ _X1D 8R?^)?<?_%4O_"Q/B#_T*_\ Y(3_ /Q=>B_L
M"_&.R^/7P&O? ?B<0ZAJ.A6_]DW=M/S]LTYXRD;,._R[XCC^XI)R]?G/^T?\
M%;_X _%S6O"5SYDMG$XN-/NI 1]HM'),;^Y&"K8_B1AVK]$O@G\,_P!FOX!>
M-D\4>%OC!IB:A]GDM9(;KQ;820S1. 2KJ-I(W*K#GJ@-7/\ @H'\";;XV?!B
M#QIX=6*_UOP[ ;^VFM")!>V#J&E567[X"A95//W6 ^_7R649YALIXDFZ$90P
MN):TE%QY9OM?I?[E+R.ZOAIU\(N9ISAV=[K^OR,_XMZ#<>%_%%KX@TX-#'.X
M??&H(CG4Y)(Q@!L!N<[B'SVKUSPSKT/B;0[34H,*)DRT8.?+<<,F<<X.1GOC
M->0>(_$GC/Q1I,VGWGAEO)<JPDCT^<.I##D$DX.,CIT)I/@YXHET'7I="O\
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MS:BBBOWT^7-.BBBBBBB@ HHHHKVG]C+_ ).C^''_ &%%_P#0&KQ:O:?V,O\
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MD*R3:U/?IWS'<-]H0_\ ?,JU^0\/_N^,,SIRT;2?R]W_ #1[V*UP-%H\@_:
M^]H7_;?_ -IUZ/X/_P"11T3_ *\8/_1:UYQ^T ISH+[6*CS\G''_ "SX->B>
M!YTN/!NB/&ZN/L<2DJ<C<$ 8?4$$?A7C]%%%?KQX)MT445]6_P#!,W_DZ*R_
M[!5Y_P"@K78_\%8/^2T^$O\ L7Q_Z4S5C_\ !+GP[<ZI^T-?ZHB.+33-%G>6
M3;\N^1XT12?4@N1_N&KO_!5;5(;KX]Z!91E7>T\/1>;M/*LUQ.=I]]NT_P#
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M=;">RDTYQVL[Z?UI]P[XW>%VCDM_$5FI212L5R\?!4@C9)P.O;).>$ %=WX
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MJ!J7AK3;71/B?I-QX@@@3RTUW32OVLJ.GFQ,0LA_VPRG Y#')/P117AYODF
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M110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
M4445+#=36_\ JII(O]QB*M+XAU5>FIW@^D[_ .-4** VV&/$DGWT5O\ >&:J
M2:'ILHP^GVKCT:!3_2KU%?K=_P $T[B74OV:GENY'NI1KEVOF3,7;&R+N:^F
MKIC&I"DQC_8XKY@_X)C?\FQR?]AV[_\ 0(J^GKS^*OXNXG_Y'V+_ ,;_ #/T
MG ?[K3]$>+_$^1M(\86MM8'[% ;%&*6_[M<^9)V4=>.M7]!A34-INU6Y9?\
MGL-_\ZS_ (N_\CY9_P#7@O\ Z,DK1\)_ZI:YK4KR=<XN)<?]=&_QKB=<N[AE
M;-S-SQ_K&/\ 6NQU3J?I7$:W_%48-*ZT-JAVFE:;9Q_<LX$_W8U']*V8XTC
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MCO@&O0M%^+7AS5S'&]V=/G?.([Q=@X'7?RN/QKL:YF^^&?AC4)1)+I$*$+M
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M76E8TW3(2$;<-\ 7AFWDCYV/& ,$ C&W):O7_K38HDAC2.-%CC0!511@ #H
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M***^A.0*****Z3X;_P#)1?"W_85M?_1R5S=7-,U&XT?4+6_M)?)N[>59X9,
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MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBOUI_P""8W_)L<G_ &';O_T"*OIZ\_BKYA_X)C?\FQR?
M]AV[_P#0(J^GKS^*OXNXG_Y'V+_QO\S])R__ ':GZ(\6^+O_ "/EG_UX+_Z,
MDK1\)_ZI:SOB[_R/EG_UX+_Z,DK1\)_ZI:Y75.I^E<1K?\5=OJG4_2N(UO\
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M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBOUI_X)C?\FQR?]AV[_\ 0(J^GKS^*OF'_@F-_P F
MQR?]AV[_ /0(J^F-<OK;2[&ZO+VYAM+6",RSW%Q((XXD'5F9N !ZFOXOXF3>
M?XM+^=_F?I. _P!UI^B/%OB[_P CY9_]>"_^C)*T?"?^J6L[XN_\CY9_]>"_
M^C)*T/"O)15)DDD. !R22,XX]N?05S>J=3]*XO75\JUEN9GCMK1.9+FX=8HD
M^KL0HKYA_: _X**Z=I,]SH_PRLX]7NE8H_B#4(C]G0]/W$)P9/9WP./N,#FO
MB+Q]\5_%_P 4M0^V^*_$-]K<H.42XE/E1^R1C"(/]T"OT/(^!\QQ<%5Q+]C%
M]U>7_@.EOFT_(\O%9K1IOEI^\_P^\[[3N]:'F(K;2WSXSM')QZXJE8Z5.R[K
MA_)1A_J8CANA^\PZ=1]WN.IK6CC2)=J*%'HHQ7WIXZ_:(^%GADRI=^,XM5NE
M_P"77P_;M?,?I(2D)_"2O#?%'[9'AH/(NA>";O4"/NW&NZEL0_6&!01_W]-?
M)]%?J^#X2R_#)>T<IOS=O_2;?BV?/U,RK5-K+^O.Y"WF[6V1Y8=-[;0?RR?T
MIWDL=V7X/3 Y'YU-17LVM_M8>/M14KI<VF^%H2<A=#L4AD'_ &U;=+_X_7E>
MN>(=5\37SWNKZE>:K>-PUQ?7#32'_@3$FLVBOJ</@L+A?X%-1]%K\WNSSYU:
ME3XY-C/+7ZTZEHHHHHKM,@HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *****
M*** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M"BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBB
MBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB
M@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HH
MHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHH
MHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH *
M******* "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHK]:O^"8O_)L
MC?\ 8<N__0(J^4?V[_VKKGXM>++OP3X;O63P5I,YCF>%L+J=PC8,A(^]$I'R
M#H2-W.5V]Q\'?B])\'?^"<?B+4;&?R-8U+7+G2K%U.&226.,,X]UC#L#Z@5\
M%U^1</Y!3K9]CLWQ$;\M2487[]9?*Z2^?6Q[^*Q3CA:6'@]TF_\ (\5^,!QX
MXM#V^P+_ .AR5Z/X+\-_V+IZ37$8&H2KE^<^6"<[ ?YGN>YP*Q-4T$:S\7+*
M:56:"RTZ.=LKE2XEDV#/8Y^;_@%=]11117ZZ> %%%%%%%% !11111110 444
M44444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4444444
M4 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%
M%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%
M%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !
M11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111
M1110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
M 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444
M44444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4444444
M4 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%
M%%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%
M%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !
M11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1111
M1110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110
M 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444
M44444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 4444444
M4 %%%%%%%% !11111110 44444444 %%%%>H^)/B%;W7[/?@KP7:W&Z6TUG4
M=2O[?!&TNL"0MGO\HEKRZBBN;#X>&&BXPZN4OG)MO\_N+G-S=WY+[BM'8I'J
M4]X/]9+%'$?HA<C_ -#-6:******Z2 HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
MHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH
M******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ****
M**** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ********
M "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BB
MBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBB
MB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ H
MHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHH
KHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHK_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
